Academic Journal
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice
| Τίτλος: | A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice |
|---|---|
| Συγγραφείς: | Errico F., D'Argenio V., Sforazzini F., Iasevoli F., Squillace M., Guerri G., Napolitano F., Angrisano T., Di Maio A., Keller S., Vitucci D., Galbusera A., Chiariotti L., Bertolino A., De Bartolomeis A., Salvatore F., Gozzi A., Usiello A. |
| Συνεισφορές: | Errico, F., D'Argenio, V., Sforazzini, F., Iasevoli, F., Squillace, M., Guerri, G., Napolitano, F., Angrisano, T., Di Maio, A., Keller, S., Vitucci, D., Galbusera, A., Chiariotti, L., Bertolino, A., De Bartolomeis, A., Salvatore, F., Gozzi, A., Usiello, A. |
| Έτος έκδοσης: | 2015 |
| Συλλογή: | Università degli Studi di Bari Aldo Moro: CINECA IRIS |
| Θεματικοί όροι: | Adult, Animal, Behavior, Brain, Case-Control Studie, D-Aspartate Oxidase, DNA Methylation, Disease Models, Excitatory Amino Acid Antagonist, Female, Functional Neuroimaging, Human, Magnetic Resonance Imaging, Male, Mice, Knockout, Middle Aged, Motor Activity, Phencyclidine, Prefrontal Cortex, Prepulse Inhibition, Schizophrenia |
| Περιγραφή: | Pharmacogenetics may allow for a personalized treatment, but a combination with clinical variables may further enhance prediction. In particular, in the present paper, we investigated early partial improvement (EPI) defined as 20% or more improvement by rating scales 2weeks after treatment, in combination with selected gene variants as a predictor of treatment outcome in patients with major depressive disorder. Two randomized controlled trials with 168 Japanese depressed patients were used. A stepwise multiple linear regression model with HAM-D score change at week 6 as the dependent variable and genotypes, EPI, baseline HAM-D score, age and sex as independent variables was performed in paroxetine, fluvoxamine and milnacipran, respectively, to estimate the prediction of HAM-D change at week 6. In the paroxetine sample, only EPI (P<0.001) was significantly associated with HAM-D change (n=81, R 2 =0.25, P<0.001). In the fluvoxamine sample, 5-HTTLPR La/Lg, S (P=0.029), FGF2 rs1449683C/T (P=0.013) and EPI (P=0.003) were associated with HAM-D change (n=42, R 2 =0.43, P<0.001). In the milnacipran sample, HTR-1A-1019C/G (P=0.001), ADRA2A-1297C/G (P=0.028) and EPI (P<0.001) were associated with outcome (n=45, R 2 =0.71, P<0.001). EPI in combination with genetic variants could be a useful predictor of treatment outcome and could strengthen the practical use of pharmacogenetic data in clinical practice. |
| Τύπος εγγράφου: | article in journal/newspaper |
| Γλώσσα: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/25689573; info:eu-repo/semantics/altIdentifier/wos/WOS:000367652000005; volume:5; issue:2; firstpage:e512; numberofpages:9; journal:TRANSLATIONAL PSYCHIATRY; https://hdl.handle.net/11586/257047; http://www.nature.com/tp/index.html |
| DOI: | 10.1038/tp.2015.2 |
| Διαθεσιμότητα: | https://hdl.handle.net/11586/257047 https://doi.org/10.1038/tp.2015.2 http://www.nature.com/tp/index.html |
| Rights: | info:eu-repo/semantics/openAccess ; license:NON PUBBLICO - Accesso privato/ristretto |
| Αριθμός Καταχώρησης: | edsbas.6CD5D327 |
| Βάση Δεδομένων: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://hdl.handle.net/11586/257047# Name: EDS - BASE (ns324271) Category: fullText Text: View record from BASE |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.6CD5D327 RelevancyScore: 850 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 849.549011230469 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Errico+F%2E%22">Errico F.</searchLink><br /><searchLink fieldCode="AR" term="%22D'Argenio+V%2E%22">D'Argenio V.</searchLink><br /><searchLink fieldCode="AR" term="%22Sforazzini+F%2E%22">Sforazzini F.</searchLink><br /><searchLink fieldCode="AR" term="%22Iasevoli+F%2E%22">Iasevoli F.</searchLink><br /><searchLink fieldCode="AR" term="%22Squillace+M%2E%22">Squillace M.</searchLink><br /><searchLink fieldCode="AR" term="%22Guerri+G%2E%22">Guerri G.</searchLink><br /><searchLink fieldCode="AR" term="%22Napolitano+F%2E%22">Napolitano F.</searchLink><br /><searchLink fieldCode="AR" term="%22Angrisano+T%2E%22">Angrisano T.</searchLink><br /><searchLink fieldCode="AR" term="%22Di+Maio+A%2E%22">Di Maio A.</searchLink><br /><searchLink fieldCode="AR" term="%22Keller+S%2E%22">Keller S.</searchLink><br /><searchLink fieldCode="AR" term="%22Vitucci+D%2E%22">Vitucci D.</searchLink><br /><searchLink fieldCode="AR" term="%22Galbusera+A%2E%22">Galbusera A.</searchLink><br /><searchLink fieldCode="AR" term="%22Chiariotti+L%2E%22">Chiariotti L.</searchLink><br /><searchLink fieldCode="AR" term="%22Bertolino+A%2E%22">Bertolino A.</searchLink><br /><searchLink fieldCode="AR" term="%22De+Bartolomeis+A%2E%22">De Bartolomeis A.</searchLink><br /><searchLink fieldCode="AR" term="%22Salvatore+F%2E%22">Salvatore F.</searchLink><br /><searchLink fieldCode="AR" term="%22Gozzi+A%2E%22">Gozzi A.</searchLink><br /><searchLink fieldCode="AR" term="%22Usiello+A%2E%22">Usiello A.</searchLink> – Name: Author Label: Contributors Group: Au Data: Errico, F.<br />D'Argenio, V.<br />Sforazzini, F.<br />Iasevoli, F.<br />Squillace, M.<br />Guerri, G.<br />Napolitano, F.<br />Angrisano, T.<br />Di Maio, A.<br />Keller, S.<br />Vitucci, D.<br />Galbusera, A.<br />Chiariotti, L.<br />Bertolino, A.<br />De Bartolomeis, A.<br />Salvatore, F.<br />Gozzi, A.<br />Usiello, A. – Name: DatePubCY Label: Publication Year Group: Date Data: 2015 – Name: Subset Label: Collection Group: HoldingsInfo Data: Università degli Studi di Bari Aldo Moro: CINECA IRIS – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Animal%22">Animal</searchLink><br /><searchLink fieldCode="DE" term="%22Behavior%22">Behavior</searchLink><br /><searchLink fieldCode="DE" term="%22Brain%22">Brain</searchLink><br /><searchLink fieldCode="DE" term="%22Case-Control+Studie%22">Case-Control Studie</searchLink><br /><searchLink fieldCode="DE" term="%22D-Aspartate+Oxidase%22">D-Aspartate Oxidase</searchLink><br /><searchLink fieldCode="DE" term="%22DNA+Methylation%22">DNA Methylation</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+Models%22">Disease Models</searchLink><br /><searchLink fieldCode="DE" term="%22Excitatory+Amino+Acid+Antagonist%22">Excitatory Amino Acid Antagonist</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Functional+Neuroimaging%22">Functional Neuroimaging</searchLink><br /><searchLink fieldCode="DE" term="%22Human%22">Human</searchLink><br /><searchLink fieldCode="DE" term="%22Magnetic+Resonance+Imaging%22">Magnetic Resonance Imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Mice%22">Mice</searchLink><br /><searchLink fieldCode="DE" term="%22Knockout%22">Knockout</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Motor+Activity%22">Motor Activity</searchLink><br /><searchLink fieldCode="DE" term="%22Phencyclidine%22">Phencyclidine</searchLink><br /><searchLink fieldCode="DE" term="%22Prefrontal+Cortex%22">Prefrontal Cortex</searchLink><br /><searchLink fieldCode="DE" term="%22Prepulse+Inhibition%22">Prepulse Inhibition</searchLink><br /><searchLink fieldCode="DE" term="%22Schizophrenia%22">Schizophrenia</searchLink> – Name: Abstract Label: Description Group: Ab Data: Pharmacogenetics may allow for a personalized treatment, but a combination with clinical variables may further enhance prediction. In particular, in the present paper, we investigated early partial improvement (EPI) defined as 20% or more improvement by rating scales 2weeks after treatment, in combination with selected gene variants as a predictor of treatment outcome in patients with major depressive disorder. Two randomized controlled trials with 168 Japanese depressed patients were used. A stepwise multiple linear regression model with HAM-D score change at week 6 as the dependent variable and genotypes, EPI, baseline HAM-D score, age and sex as independent variables was performed in paroxetine, fluvoxamine and milnacipran, respectively, to estimate the prediction of HAM-D change at week 6. In the paroxetine sample, only EPI (P<0.001) was significantly associated with HAM-D change (n=81, R 2 =0.25, P<0.001). In the fluvoxamine sample, 5-HTTLPR La/Lg, S (P=0.029), FGF2 rs1449683C/T (P=0.013) and EPI (P=0.003) were associated with HAM-D change (n=42, R 2 =0.43, P<0.001). In the milnacipran sample, HTR-1A-1019C/G (P=0.001), ADRA2A-1297C/G (P=0.028) and EPI (P<0.001) were associated with outcome (n=45, R 2 =0.71, P<0.001). EPI in combination with genetic variants could be a useful predictor of treatment outcome and could strengthen the practical use of pharmacogenetic data in clinical practice. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article in journal/newspaper – Name: Language Label: Language Group: Lang Data: English – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: info:eu-repo/semantics/altIdentifier/pmid/25689573; info:eu-repo/semantics/altIdentifier/wos/WOS:000367652000005; volume:5; issue:2; firstpage:e512; numberofpages:9; journal:TRANSLATIONAL PSYCHIATRY; https://hdl.handle.net/11586/257047; http://www.nature.com/tp/index.html – Name: DOI Label: DOI Group: ID Data: 10.1038/tp.2015.2 – Name: URL Label: Availability Group: URL Data: https://hdl.handle.net/11586/257047<br />https://doi.org/10.1038/tp.2015.2<br />http://www.nature.com/tp/index.html – Name: Copyright Label: Rights Group: Cpyrght Data: info:eu-repo/semantics/openAccess ; license:NON PUBBLICO - Accesso privato/ristretto – Name: AN Label: Accession Number Group: ID Data: edsbas.6CD5D327 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.6CD5D327 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/tp.2015.2 Languages: – Text: English Subjects: – SubjectFull: Adult Type: general – SubjectFull: Animal Type: general – SubjectFull: Behavior Type: general – SubjectFull: Brain Type: general – SubjectFull: Case-Control Studie Type: general – SubjectFull: D-Aspartate Oxidase Type: general – SubjectFull: DNA Methylation Type: general – SubjectFull: Disease Models Type: general – SubjectFull: Excitatory Amino Acid Antagonist Type: general – SubjectFull: Female Type: general – SubjectFull: Functional Neuroimaging Type: general – SubjectFull: Human Type: general – SubjectFull: Magnetic Resonance Imaging Type: general – SubjectFull: Male Type: general – SubjectFull: Mice Type: general – SubjectFull: Knockout Type: general – SubjectFull: Middle Aged Type: general – SubjectFull: Motor Activity Type: general – SubjectFull: Phencyclidine Type: general – SubjectFull: Prefrontal Cortex Type: general – SubjectFull: Prepulse Inhibition Type: general – SubjectFull: Schizophrenia Type: general Titles: – TitleFull: A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Errico F. – PersonEntity: Name: NameFull: D'Argenio V. – PersonEntity: Name: NameFull: Sforazzini F. – PersonEntity: Name: NameFull: Iasevoli F. – PersonEntity: Name: NameFull: Squillace M. – PersonEntity: Name: NameFull: Guerri G. – PersonEntity: Name: NameFull: Napolitano F. – PersonEntity: Name: NameFull: Angrisano T. – PersonEntity: Name: NameFull: Di Maio A. – PersonEntity: Name: NameFull: Keller S. – PersonEntity: Name: NameFull: Vitucci D. – PersonEntity: Name: NameFull: Galbusera A. – PersonEntity: Name: NameFull: Chiariotti L. – PersonEntity: Name: NameFull: Bertolino A. – PersonEntity: Name: NameFull: De Bartolomeis A. – PersonEntity: Name: NameFull: Salvatore F. – PersonEntity: Name: NameFull: Gozzi A. – PersonEntity: Name: NameFull: Usiello A. – PersonEntity: Name: NameFull: Errico, F. – PersonEntity: Name: NameFull: D'Argenio, V. – PersonEntity: Name: NameFull: Sforazzini, F. – PersonEntity: Name: NameFull: Iasevoli, F. – PersonEntity: Name: NameFull: Squillace, M. – PersonEntity: Name: NameFull: Guerri, G. – PersonEntity: Name: NameFull: Napolitano, F. – PersonEntity: Name: NameFull: Angrisano, T. – PersonEntity: Name: NameFull: Di Maio, A. – PersonEntity: Name: NameFull: Keller, S. – PersonEntity: Name: NameFull: Vitucci, D. – PersonEntity: Name: NameFull: Galbusera, A. – PersonEntity: Name: NameFull: Chiariotti, L. – PersonEntity: Name: NameFull: Bertolino, A. – PersonEntity: Name: NameFull: De Bartolomeis, A. – PersonEntity: Name: NameFull: Salvatore, F. – PersonEntity: Name: NameFull: Gozzi, A. – PersonEntity: Name: NameFull: Usiello, A. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2015 Identifiers: – Type: issn-locals Value: edsbas – Type: issn-locals Value: edsbas.oa |
| ResultId | 1 |